As scrutiny mounts on pricing; biosimilars begin to enter the market; companies and portfolios merge; payers become more aggressive with coverage restrictions, discount demands and the discussion of value become more focused; specialty manufacturers are increasingly challenged to understand, manage and adapt to the impacts of these forces. Join Pharosity Consulting at this year's Asembia Summit, April 29 - May 2 at the Wynn in Las Vegas, to discuss how operational models, contracting and pricing, gross-to-net forecasting and analytics impact and can be optimized to make the most of the changing market dynamics.